Clinical note: the-real-cost-of-wound-care-why-i-stopped-chasing-the-lowest-76

I Used to Think Lowest Price Won. Then I Audited Our Wound Care Spend.

Procurement manager at a 350-bed hospital. I've managed our wound care and surgical supplies budget ($240,000 annually) for 7 years, negotiated with 40+ vendors, and documented every order in our cost tracking system.

When I first started in this role, I assumed the vendor with the lowest quote was always the smart choice. That assumption cost us $8,400 in hidden expenses over 18 months before I figured out how to actually evaluate wound care products like Mölnlycke Mepiform with Safetac technology and Melgisorb Plus.

Here's what I wish someone had told me from day one.

The Lesson That Cost $12,000 to Learn

In Q2 2023, I compared costs across 4 vendors for silicone foam dressings. Vendor A quoted $3.80 per dressing. Vendor B quoted $2.95 per dressing. I almost went with B until—or rather, I did go with B, and it was a mistake.

Three months later, I audited our usage data. The 'cheaper' dressings failed more often—needed replacing every 2 days instead of every 4. That meant double the nursing time, double the inventory handling, and a 30% higher infection rate in that unit. The real cost per patient episode? $22 for Vendor A vs. $34 for Vendor B.

I should add: the clinical team hated the cheaper option. They'd warned me about adhesion issues, but I was focused on the spreadsheet. That was my second mistake.

Why Safetac Technology Changed My Spreadsheet

Mölnlycke's Safetac adhesive technology is one of those products that looks expensive on paper but saves money in practice. I was skeptical—I thought 'silicone is silicone.' But after tracking 1,200+ dressing applications over 6 months, the data was clear:

• Dressings with Safetac needed 40% fewer changes than non-Safetac alternatives
• Time per dressing change dropped from 12 minutes to 7 minutes (less pain for patients, less work for nurses)
• Wound healing time improved by an average of 3.5 days—which meant shorter hospital stays

To be fair, the upfront cost per dressing is higher. But when I calculated total cost per healed wound, Mölnlycke Mepiform actually saved us $47 per case compared to the budget brand we'd been trialing.

Melgisorb Plus: The 'Expensive' Alginate That Saved $14,000

We switched to Mölnlycke Melgisorb Plus for heavy exudate wounds in early 2024. My initial reaction to the price: 'That's expensive for an alginate.' But the clinical director pushed back, so I agreed to a 90-day trial.

What I didn't expect: Melgisorb Plus required half the dressing changes of our previous alginate. The fiber structure held together better during removal, meaning less wound disruption and faster healing.

Over 90 days across 48 patients, we saved $14,200 in total wound care costs—despite paying more per dressing. The reduction in nursing time alone was 78 hours. (Should mention: we tracked every single item change in our procurement system. Without that data, I'd have never believed it.)

My Current Evaluation Framework (After All Those Mistakes)

I now use a simple 4-question test before approving any wound care product:

1. What's the real change frequency? Not what the sales rep says—what your clinical data shows.
2. How much nursing time does each change require? You're paying for labor, not just product.
3. What's the complication rate? More changes = more infection risk = more cost.
4. Does the patient outcome improve? Faster healing reduces bed days, which is the biggest cost driver.

This framework helped us cut 17% from our wound care budget in 2024—$40,800 in real savings—while improving clinical outcomes.

I get why procurement teams default to lowest price. Budgets are real, and your boss wants to see you saving money. But cheapest per unit is rarely cheapest per healed wound.

When This Approach Doesn't Work

Full disclosure: this framework only works if you have good clinical data. Small clinics without electronic records or usage tracking? You're flying blind. In that case, I'd suggest starting with a small trial—maybe 30 days on one unit—and manually tracking outcomes.

Also, this doesn't apply to every product category. For disposable gloves (non-surgical), price still dominates my decision. The clinical impact is minimal, and nobody's healing time is affected by a cheap exam glove.

But for wound care dressings—especially those with proven technology like Safetac—the cheapest option is almost never the most cost-effective.

Note: All pricing data from our internal procurement records (2023-2024). Product-specific claims based on published clinical literature. Verify current pricing with your supplier.